[DPHARMA] YoY Quarter Result on 30-Jun-2019 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
30-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Jun-2019 [#2]
Profit Trend
QoQ- -3.8%
YoY- 34.6%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 181,742 155,439 143,331 145,466 123,991 117,049 79,135 14.85%
PBT 21,473 20,197 19,391 18,316 12,915 12,642 7,723 18.57%
Tax -5,162 -4,807 -4,662 -4,400 -2,576 -3,001 -3,782 5.31%
NP 16,311 15,390 14,729 13,916 10,339 9,641 3,941 26.69%
-
NP to SH 16,311 15,390 14,729 13,916 10,339 9,653 4,503 23.91%
-
Tax Rate 24.04% 23.80% 24.04% 24.02% 19.95% 23.74% 48.97% -
Total Cost 165,431 140,049 128,602 131,550 113,652 107,408 75,194 14.03%
-
Net Worth 634,375 614,350 581,725 503,029 209,983 463,071 446,334 6.03%
Dividend
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Div 4,734 3,530 3,421 6,618 4,199 6,973 6,973 -6.24%
Div Payout % 29.02% 22.94% 23.23% 47.56% 40.62% 72.25% 154.87% -
Equity
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Net Worth 634,375 614,350 581,725 503,029 209,983 463,071 446,334 6.03%
NOSH 952,239 706,330 684,383 661,881 650,902 278,959 278,959 22.69%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 8.97% 9.90% 10.28% 9.57% 8.34% 8.24% 4.98% -
ROE 2.57% 2.51% 2.53% 2.77% 4.92% 2.08% 1.01% -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
RPS 19.19 22.01 20.94 21.98 44.29 41.96 28.37 -6.30%
EPS 1.72 2.18 2.15 2.07 1.59 3.46 1.41 3.36%
DPS 0.50 0.50 0.50 1.00 1.50 2.50 2.50 -23.51%
NAPS 0.67 0.87 0.85 0.76 0.75 1.66 1.60 -13.49%
Adjusted Per Share Value based on latest NOSH - 661,881
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
RPS 18.89 16.16 14.90 15.12 12.89 12.17 8.23 14.84%
EPS 1.70 1.60 1.53 1.45 1.07 1.00 0.47 23.88%
DPS 0.49 0.37 0.36 0.69 0.44 0.72 0.72 -6.20%
NAPS 0.6595 0.6387 0.6047 0.5229 0.2183 0.4814 0.464 6.03%
Price Multiplier on Financial Quarter End Date
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Date 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 -
Price 1.20 3.03 1.62 1.37 1.30 2.25 2.04 -
P/RPS 6.25 13.77 7.74 6.23 2.94 5.36 7.19 -2.30%
P/EPS 69.66 139.03 75.27 65.16 35.20 65.02 126.38 -9.44%
EY 1.44 0.72 1.33 1.53 2.84 1.54 0.79 10.51%
DY 0.42 0.17 0.31 0.73 1.15 1.11 1.23 -16.38%
P/NAPS 1.79 3.48 1.91 1.80 1.73 1.36 1.28 5.74%
Price Multiplier on Announcement Date
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Date 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 22/08/16 -
Price 1.34 2.49 3.15 1.41 1.08 2.03 2.14 -
P/RPS 6.98 11.31 15.04 6.42 2.44 4.84 7.54 -1.27%
P/EPS 77.78 114.25 146.36 67.06 29.25 58.66 132.57 -8.49%
EY 1.29 0.88 0.68 1.49 3.42 1.70 0.75 9.45%
DY 0.37 0.20 0.16 0.71 1.39 1.23 1.17 -17.45%
P/NAPS 2.00 2.86 3.71 1.86 1.44 1.22 1.34 6.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment